Setsuro Tech
A biotech company developed a method to easily and efficiently generate genetically engineered (genome-edited) mice using CRISPR/Cas9 in 2015 and filed a patent application for the technology.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | N/A | Early VC | |
| Total Funding | 000k | ||
Related Content
SetsuroTech, founded in 2017 and originating from Tokushima University in Japan, is a biotech startup specializing in advanced genome editing techniques. The company leverages two proprietary methods: the GEEP method, which is a high-throughput genome editing technique for embryos, and the VIKING method, known for its stability and flexibility in cultured cells. These technologies enable SetsuroTech to produce genome-edited animals and cells at competitive prices and with quick turnaround times.
SetsuroTech primarily serves research institutions, pharmaceutical companies, and biotech firms that require precise genetic modifications for their studies and product development. Operating in the rapidly growing biotech market, the company’s business model revolves around the sale of genome-edited products and related services. Revenue is generated through direct sales of these products and potentially through licensing agreements.
SetsuroTech's competitive edge lies in its ability to deliver high-quality genome-edited organisms efficiently and cost-effectively, making advanced genetic research more accessible.
Keywords: genome editing, biotech, GEEP method, VIKING method, embryos, cultured cells, research institutions, pharmaceutical companies, genetic modifications, Tokushima University.